<DOC>
	<DOCNO>NCT00571285</DOCNO>
	<brief_summary>Retrospective review record Emory Movement Disorders clinic suggests vitamin D deficiency occur 80 % patient Parkinson 's Disease ( PD ) , much frequently internal medicine clinic . Laboratory study suggest vitamin D could play role development PD . In addition , low vitamin D level associate slow walk speed , bad memory thinking , depression .</brief_summary>
	<brief_title>Clinical Effects Vitamin D Repletion Patients With Parkinson 's Disease</brief_title>
	<detailed_description>Retrospective review record Emory Movement Disorders clinic suggests vitamin D deficiency occur 80 % patient Parkinson 's Disease ( PD ) , much frequently internal medicine clinic . Laboratory study suggest vitamin D could play role development PD . In addition , low vitamin D level associate slow walk speed , bad memory thinking , depression . About 150 person PD low vitamin D level participate study . Subjects randomly ( like flip coin ) assign either high dose vitamin D supplement ( 54,200 IU weekly ) Recommended Daily Allowance ( RDA ) old person ( 4200 IU weekly vitamin D ) . Subjects examine clinic , 3- 6- month take vitamin D supplement . Tests walk speed , Parkinson 's rating scale , memory test questionnaires mood , anxiety fatigue administer . If study confirm vitamin D deficiency occur 80 % patient , patient may benefit awareness problem increase . Also , study help determine whether vitamin D improve patient ' functioning . Currently , `` standard care '' person low vitamin D. At VA Medical Center , provider use variety supplement regimen . The Institute Medicine ( IOM ) publish 600 IU per day ( 4200 IU per week ) Recommended Daily Allowance ( RDA ) . By definition , RDA amount vitamin supplement prevent 97-98 % population become deficient .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Eligible participant must able provide inform consent legal representative ( define Georgia Law ) give consent . Diagnosis IPD , base history 2/3 cardinal feature PD ( tremor , bradykinesia rigidity ) definite response dopaminergic therapy . Previous serum 25OH vitamin D concentration measure treat physician within previous 3 month . Eligible participant must able complete study questionnaire assessment ( e.g. , participant must judge able complete TUG screening/baseline ) . Participants must free active cancer serious medical condition might reasonably preclude complete 6month intervention . Participants must able complete 8 meter walk screen evaluation . Patients PD , H &amp; Y stage IIV eligible participate study . Participants must age 1889 year . Patient history hypercalcemia , hypercalciuria , liver failure , endstage renal disease ( National Kidney Foundation Classification Stage 5 ) kidney stone within past 5 year exclude . Specifically , potential participant GFR ( estimate measure ) &lt; 15 ml/min exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Nutrition</keyword>
	<keyword>Vitamin supplement</keyword>
	<keyword>Motor function</keyword>
	<keyword>Non-motor function</keyword>
</DOC>